Bridgeway Capital Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $35K | Buy |
|
|||||
|
2022
Q2 | $76K | Sell |
|
|||||
|
2022
Q1 | $378K | Hold |
|
|||||
|
2021
Q4 | $748K | Buy |
|
|||||
|
2021
Q3 | $639K | Buy |
|
|||||
|
2021
Q2 | $330K | Sell |
|
|||||
|
2021
Q1 | $390K | Sell |
|
|||||
|
2020
Q4 | $429K | Sell |
|
|||||
|
2020
Q3 | $536K | Hold |
|
|||||
|
2020
Q2 | $702K | Sell |
|
|||||
|
2020
Q1 | $607K | Buy |
|
|||||
|
2019
Q4 | $1.07M | Buy |
|